2.4.0.6 Html 117 241 1 true 35 0 false 15 false false R1.htm 00 - Document - Document and Entity Information Sheet http://www.cadencepharm.com/2010-09-30/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 0110 - Statement - Condensed Balance Sheets Sheet http://www.cadencepharm.com/2010-09-30/role/BalanceSheets Condensed Balance Sheets false false R3.htm 0111 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://www.cadencepharm.com/2010-09-30/role/BalanceSheetsParenthetical Condensed Balance Sheets (Parenthetical) false false R4.htm 0120 - Statement - Condensed Statements of Operations (Unaudited) Sheet http://www.cadencepharm.com/2010-09-30/role/StatementsOfOperations Condensed Statements of Operations (Unaudited) false false R5.htm 0130 - Statement - Condensed Statements of Comprehensive Income (Unaudited) Sheet http://www.cadencepharm.com/role/StatementsOfComprehensiveIncome Condensed Statements of Comprehensive Income (Unaudited) false false R6.htm 0140 - Statement - Condensed Statements of Cash Flows (Unaudited) Sheet http://www.cadencepharm.com/2010-09-30/role/StatementsOfCashFlows Condensed Statements of Cash Flows (Unaudited) false false R7.htm 0201 - Disclosure - The Company Sheet http://www.cadencepharm.com/2010-09-30/role/Company The Company false false R8.htm 0202 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.cadencepharm.com/2010-09-30/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R9.htm 0203 - Disclosure - Recent Accounting Pronouncements Sheet http://www.cadencepharm.com/2010-09-30/role/RecentAccountingPronouncements Recent Accounting Pronouncements false false R10.htm 0204 - Disclosure - Net Loss Per Share Sheet http://www.cadencepharm.com/2010-09-30/role/NetLossPerShare Net Loss Per Share false false R11.htm 0205 - Disclosure - Inventory Sheet http://www.cadencepharm.com/2010-09-30/role/Inventory Inventory false false R12.htm 0206 - Disclosure - Property and Equipment Sheet http://www.cadencepharm.com/2010-09-30/role/PropertyAndEquipment Property and Equipment false false R13.htm 0207 - Disclosure - Investments in Marketable Securities Sheet http://www.cadencepharm.com/2010-09-30/role/InvestmentsInMarketableSecurities Investments in Marketable Securities false false R14.htm 0208 - Disclosure - Investment in Incline Sheet http://www.cadencepharm.com/2010-09-30/role/InvestmentInIncline Investment in Incline false false R15.htm 0209 - Disclosure - Restructuring and Impairment Charges Sheet http://www.cadencepharm.com/role/RestructuringAndImpairmentCharges Restructuring and Impairment Charges false false R16.htm 0210 - Disclosure - Loan and Security Agreement Sheet http://www.cadencepharm.com/2010-09-30/role/LoanAndSecurityAgreement Loan and Security Agreement false false R17.htm 0211 - Disclosure - Commitments and Contingencies Sheet http://www.cadencepharm.com/2010-09-30/role/CommitmentsAndContingencies Commitments and Contingencies false false R18.htm 0212 - Disclosure - Stockholder's Equity Sheet http://www.cadencepharm.com/role/StockholdersEquity Stockholder's Equity false false R19.htm 0213 - Disclosure - Segment Information Sheet http://www.cadencepharm.com/2010-09-30/role/SegmentInformation Segment Information false false R20.htm 0214 - Disclosure - Income Taxes Sheet http://www.cadencepharm.com/2010-09-30/role/IncomeTaxes Income Taxes false false R21.htm 0402 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.cadencepharm.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) false false R22.htm 0502 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.cadencepharm.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) false false R23.htm 0504 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.cadencepharm.com/role/NetLossPerShareTables Net Loss Per Share (Tables) false false R24.htm 0505 - Disclosure - Inventory (Tables) Sheet http://www.cadencepharm.com/role/InventoryTables Inventory (Tables) false false R25.htm 0506 - Disclosure - Property and Equipment (Tables) Sheet http://www.cadencepharm.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) false false R26.htm 0507 - Disclosure - Investments in Marketable Securities (Tables) Sheet http://www.cadencepharm.com/role/InvestmentsInMarketableSecuritiesTables Investments in Marketable Securities (Tables) false false R27.htm 0509 - Disclosure - Restructuring and Impairment Charges (Tables) Sheet http://www.cadencepharm.com/role/RestructuringAndImpairmentChargesTables Restructuring and Impairment Charges (Tables) false false R28.htm 0513 - Disclosure - Segment Information (Tables) Sheet http://www.cadencepharm.com/role/SegmentInformationTables Segment Information (Tables) false false R29.htm 0601 - Disclosure - The Company (Details) Sheet http://www.cadencepharm.com/role/CompanyDetails The Company (Details) false false R30.htm 0602 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.cadencepharm.com/role/SummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) false false R31.htm 06021 - Disclosure - Summary of Significant Accounting Policies (Details 1) Sheet http://www.cadencepharm.com/role/SummaryOfSignificantAccountingPoliciesDetails1 Summary of Significant Accounting Policies (Details 1) false false R32.htm 06022 - Disclosure - Summary of Significant Accounting Policies (Details 2) Sheet http://www.cadencepharm.com/role/SummaryOfSignificantAccountingPoliciesDetails2 Summary of Significant Accounting Policies (Details 2) false false R33.htm 06023 - Disclosure - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.cadencepharm.com/role/SummaryOfSignificantAccountingPoliciesDetailsTextual Summary of Significant Accounting Policies (Details Textual) false false R34.htm 0604 - Disclosure - Net Loss Per Share (Details) Sheet http://www.cadencepharm.com/role/NetLossPerShareDetails Net Loss Per Share (Details) false false R35.htm 06041 - Disclosure - Net Loss Per Share (Details Textual) Sheet http://www.cadencepharm.com/role/NetLossPerShareDetailsTextual Net Loss Per Share (Details Textual) false false R36.htm 0605 - Disclosure - Inventory (Details) Sheet http://www.cadencepharm.com/role/InventoryDetails Inventory (Details) false false R37.htm 06051 - Disclosure - Inventory (Details Textual) Sheet http://www.cadencepharm.com/role/InventoryDetailsTextual Inventory (Details Textual) false false R38.htm 0606 - Disclosure - Property and Equipment (Details) Sheet http://www.cadencepharm.com/role/PropertyAndEquipmentDetails Property and Equipment (Details) false false R39.htm 06061 - Disclosure - Property and Equipment (Details Textual) Sheet http://www.cadencepharm.com/role/PropertyAndEquipmentDetailsTextual Property and Equipment (Details Textual) false false R40.htm 0607 - Disclosure - Investments in Marketable Securities (Details) Sheet http://www.cadencepharm.com/role/InvestmentsInMarketableSecuritiesDetails Investments in Marketable Securities (Details) false false R41.htm 06071 - Disclosure - Investments in Marketable Securities (Details 1) Sheet http://www.cadencepharm.com/role/InvestmentsInMarketableSecuritiesDetails1 Investments in Marketable Securities (Details 1) false false R42.htm 06072 - Disclosure - Investments in Marketable Securities (Details Textual) Sheet http://www.cadencepharm.com/role/InvestmentsInMarketableSecuritiesDetailsTextual Investments in Marketable Securities (Details Textual) false false R43.htm 0608 - Disclosure - Investment in Incline (Details) Sheet http://www.cadencepharm.com/role/InvestmentInInclineDetails Investment in Incline (Details) false false R44.htm 0609 - Disclosure - Restructuring and Impairment Charges (Details) Sheet http://www.cadencepharm.com/role/RestructuringAndImpairmentChargesDetails Restructuring and Impairment Charges (Details) false false R45.htm 06091 - Disclosure - Restructuring and Impairment Charges (Details Textual) Sheet http://www.cadencepharm.com/role/RestructuringAndImpairmentChargesDetailsTextual Restructuring and Impairment Charges (Details Textual) false false R46.htm 0610 - Disclosure - Loan and Security Agreement (Details) Sheet http://www.cadencepharm.com/role/LoanAndSecurityAgreementDetails Loan and Security Agreement (Details) false false R47.htm 0611 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.cadencepharm.com/role/CommitmentsAndContingenciesDetails Commitments and Contingencies (Details) false false R48.htm 0612 - Disclosure - Stockholder's Equity (Details) Sheet http://www.cadencepharm.com/role/StockholdersEquityDetails Stockholder's Equity (Details) false false R49.htm 0613 - Disclosure - Segment Information (Details) Sheet http://www.cadencepharm.com/role/SegmentInformationDetails Segment Information (Details) false false R50.htm 06131 - Disclosure - Segment Information (Details Textual) Sheet http://www.cadencepharm.com/role/SegmentInformationDetailsTextual Segment Information (Details Textual) false false R51.htm 0614 - Disclosure - Income Taxes (Details) Sheet http://www.cadencepharm.com/role/IncomeTaxesDetails Income Taxes (Details) false false All Reports Book All Reports Element us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights had a mix of decimals attribute values: 2 3 4. Element us-gaap_Depreciation had a mix of decimals attribute values: -3 0. Element us-gaap_ProceedsFromIssuanceOfCommonStock had a mix of decimals attribute values: -3 0. 'Monetary' elements on report '0140 - Statement - Condensed Statements of Cash Flows (Unaudited)' had a mix of different decimal attribute values. 'Monetary' elements on report '0609 - Disclosure - Restructuring and Impairment Charges (Details)' had a mix of different decimal attribute values. Process Flow-Through: 0110 - Statement - Condensed Balance Sheets Process Flow-Through: Removing column 'Jun. 30, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 0111 - Statement - Condensed Balance Sheets (Parenthetical) Process Flow-Through: 0120 - Statement - Condensed Statements of Operations (Unaudited) Process Flow-Through: 0130 - Statement - Condensed Statements of Comprehensive Income (Unaudited) Process Flow-Through: 0140 - Statement - Condensed Statements of Cash Flows (Unaudited) cadx-20120630.xml cadx-20120630.xsd cadx-20120630_cal.xml cadx-20120630_def.xml cadx-20120630_lab.xml cadx-20120630_pre.xml true true